RecruitingNot ApplicableNCT06356168

Virtual Reality in End Stage Kidney Disease

Social Virtual Reality to Alleviate Loneliness and Symptoms for Individuals Receiving Hemodialysis


Sponsor

University of Pennsylvania

Enrollment

60 participants

Start Date

Mar 30, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.


Eligibility

Inclusion Criteria1

  • Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month

Exclusion Criteria3

  • Acutely ill
  • Active nausea
  • Epilepsy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSocial Virtual Reality

Participants interact using virtual reality during dialysis.

BEHAVIORALIndividual Virtual Reality

Participants use virtual reality alone during dialysis.


Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06356168


Related Trials